Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials.

MLA

Axfors, Cathrine, et al. “Mortality Outcomes with Hydroxychloroquine and Chloroquine in COVID-19 from an International Collaborative Meta-Analysis of Randomized Trials.” Nature Communications, vol. 12, no. 1, Apr. 2021, p. 2349. EBSCOhost, https://doi.org/10.1038/s41467-021-22446-z.

APA

Axfors, C., Schmitt, A. M., Janiaud, P., Van’t Hooft, J., Abd-Elsalam, S., Abdo, E. F., Abella, B. S., Akram, J., Amaravadi, R. K., Angus, D. C., Arabi, Y. M., Azhar, S., Baden, L. R., Baker, A. W., Belkhir, L., Benfield, T., Berrevoets, M. A. H., Chen, C.-P., Chen, T.-C., … Hemkens, L. G. (2021). Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials. Nature Communications, 12(1), 2349. https://doi.org/10.1038/s41467-021-22446-z

Chicago

Axfors, Cathrine, Andreas M Schmitt, Perrine Janiaud, Janneke Van’t Hooft, Sherief Abd-Elsalam, Ehab F Abdo, Benjamin S Abella, et al. 2021. “Mortality Outcomes with Hydroxychloroquine and Chloroquine in COVID-19 from an International Collaborative Meta-Analysis of Randomized Trials.” Nature Communications 12 (1): 2349. doi:10.1038/s41467-021-22446-z.